MTOR and colorectal cancer: In contrast, mTOR inhibitors appear to be more effective when combined with cytotoxic chemotherapy and in one phase I clinical trial, the combination of RAD001 with 5-fluorouracil in a refractory colorectal cancer patient population resulted in one PR lasting 7.4 months.[30]